Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Rescue and booster medicine used with methotrexate and fluorouracil. | Once-weekly anchor drug for rheumatoid arthritis. |
| Body system | Cancer | Joints & Immunity |
| Drug class | Chemotherapy rescue agents | Conventional DMARDs |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Methotrexate rescue, Colorectal cancer (with fluorouracil), Megaloblastic anaemia (rarely) | Rheumatoid arthritis, Psoriasis and psoriatic arthritis, Crohn's disease, Some cancers (high dose), Ectopic pregnancy |
| How it works | Protects healthy cells from methotrexate and boosts fluorouracil. | Calms an overactive immune system (low dose) or stops cancer cells dividing (high dose). |
| Starts working | Depends on the cancer and regimen | 6–12 weeks for arthritis |
| Half-life | About 6 hours | 3–10 hours (low dose) |
| Typical adult dose | Dosed by your cancer team according to the treatment protocol. | Arthritis: 7.5–25 mg ONCE A WEEK on the same day, with folic acid on a different day. |
| Forms | IV injection, Tablet, Intramuscular injection | Tablet (2.5 mg), Pre-filled pen, Injection |
| Common side effects | Nausea, Diarrhoea (with fluorouracil) | Nausea, Mouth ulcers, Tiredness the day after, Hair thinning |
| Serious side effects | Allergic reaction (rare), Seizures if given into the spine | Bone marrow suppression, Liver scarring, Lung inflammation, Severe infections |
| Don't take if | Pernicious anaemia and B12 deficiency (can mask) | Pregnancy and breastfeeding; Severe kidney or liver disease; Active serious infection; Taking trimethoprim or co-trimoxazole |
| Alcohol | Usually no problem in moderation. No specific interaction. | Best avoided. Alcohol adds to liver damage. |
| Pregnancy | Generally considered safeUsed when needed. | Usually avoidedCauses miscarriage and birth defects; stop 3 months before trying (both partners per some guidance). |
| Breastfeeding | Generally considered safeConsidered acceptable. | Usually avoidedAvoid. |
| In use since | — | 1953 |
| Brand names | United States: Leucovorin (generic), FusilevUnited Kingdom: Calcium folinate (generic)India: Leucovorin (generic), Folinic acid (generic) | United States: Trexall, Otrexup, RasuvoUnited Kingdom: Maxtrex, Metoject, NordimetIndia: Folitrax, Imutrex |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | V03AF03 | L04AX03 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker